Mostrando ítems 1-5 de 5
Proposal for the inclusion of misoprostol in the WHO model list of essential medicines
(World Health Organization, 2009)
Misoprostol in addition to routine treatment of postpartum hemorrhage: A hospital-based randomized-controlled trial in Karachi, Pakistan
(BioMed Central, 2008-08)
Background: Postpartum hemorrhage (PPH) remains a major killer of women worldwide. Standard uterotonic treatments used to control postpartum bleeding do not always work and are not always available. Misoprostol's potential ...